Tauriga Sciences, Inc.
Period Ending Mar 31, 2014 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development - - - 471
Sales, General and Admin. 6,142 8,374 3,767 1,763
Non-Recurring Items 1,356 2,714 819 -
Other 111 44 3 4
Operating Income (7,609) (11,132) (4,589) (2,238)
Income From Continuing Operations
Add'l Income/Expense Items (1,799) (4) - -
Earnings Before Interest and Tax (9,409) (11,136) (4,589) (2,238)
Interest Expense 573 11 6 574
Earnings Before Tax (9,981) (11,147) (4,595) (2,812)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (9,981) (11,147) (4,595) (2,812)
Non Recurring Events
Discontinued Operations - - (1,651) -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (9,981) (11,147) (6,246) (2,812)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (9,981) (11,147) (6,246) (2,812)